Fitbit Data for Detecting Infections After Appendicitis Surgery
(i-DETECT Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to analyze Fitbit data to predict infection after surgery for complicated appendicitis and the effect this prediction has on clinician decision making.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Infection-Prediction Algorithm for detecting infections after appendicitis surgery?
Is it safe to use Fitbit data for detecting infections after appendicitis surgery?
How does the Infection-Prediction Algorithm treatment differ from other treatments for detecting infections after appendicitis surgery?
The Infection-Prediction Algorithm uses data from a Fitbit wearable device to monitor physical activity, heart rate, and sleep, allowing for early detection of abnormal recovery patterns after appendicitis surgery. This approach is unique because it provides objective, real-time monitoring at home, unlike traditional methods that rely on subjective assessments by caregivers.26789
Research Team
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Fizan Abdullah, MD, PhD
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Hassan Ghomrawi, PhD, MPH
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for pediatric patients who have undergone surgery for complicated appendicitis. Specific eligibility criteria are not provided, but typically participants would be children with recent appendectomies.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Postoperative Monitoring
Participants' Fitbit data (PA, HR, Sleep) is collected and analyzed using ML methods to predict infection during the recovery period.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including daily diary/survey submissions for symptoms and healthcare utilization.
Implementation of Algorithm
Clinicians receive daily reports and near real-time alerts based on Fitbit data to assess the impact on clinical decision-making and healthcare utilization.
Treatment Details
Interventions
- Infection-Prediction Algorithm (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ann & Robert H Lurie Children's Hospital of Chicago
Lead Sponsor
Dr. Michael D. Kelleher
Ann & Robert H Lurie Children's Hospital of Chicago
Chief Medical Officer since 2012
MD from University of Chicago
Dr. Thomas Shanley
Ann & Robert H Lurie Children's Hospital of Chicago
Chief Executive Officer since 2019
MD from University of Chicago Pritzker School of Medicine
Loyola University Chicago
Collaborator
Northwestern University
Collaborator
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech
Central DuPage Hospital
Collaborator
University of Chicago
Collaborator
Pete Salzmann
University of Chicago
Chief Executive Officer since 2018
MD from University of Chicago’s Pritzker School of Medicine, MBA from Stanford University’s Graduate School of Business
Anh Nguyen
University of Chicago
Chief Medical Officer
MD from Rutgers New Jersey Medical School, MBA from University of Chicago